MBX Biosciences, Inc.
Pharmaceutical Preparations · Carmel, IN, United States
- PrincipalsJohn W SmitherChief Financial OfficerP. Kent HawrylukPresident & CEORichard BartramChief Financial Officerand 3 more
- CompanyMBX Biosciences, Inc.Carmel, IN, United States
- Phone line+1 (317) 989-3100General business
MBX Biosciences, Inc. is an SEC-registered Nasdaq-listed company (ticker MBX) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 6
Chief executive
P. Kent HawrylukPresident & CEO
Everyone else on file (1)
Salomon AzoulayChief Medical Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗John W Smither — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗P. Kent Hawryluk — President & CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Richard Bartram — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Salomon Azoulay — Chief Medical Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Cannapharmarx, Inc.Pharmaceutical Preparations · Mountain View County1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityChemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityBeOne Medicines Ltd.Pharmaceutical Preparations · Basel1 shared capabilityInMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityMereo BioPharma Group plcPharmaceutical Preparations · London1 shared capability